An Immunohistochemical Study of PRAME Expression in Non-hodgkin’s Lymphoma
Journal Title: International Blood Research & Reviews - Year 2014, Vol 2, Issue 6
Abstract
Aim: Preferentially expressed antigen of melanoma (PRAME) is a cancer-testis antigen with very low/no expression in normal tissues. PRAME is an important target for tumor immunotherapy. Prognostic and in some tumors predictive importance of this expression have been shown in some solid tumors. The aim of this study is to detect the prognostic and/or predictive value of PRAME expression in non-Hodgkin’s lymphomas (NHL). Study Design: Retrospective clinico-pathological study. Methodology: PRAME expression was determined by immunohistochemistry (IHC) in 62 cases with NHL. However statistical analysis was performed in 54 cases [33 with diffuse large B cell lymphoma (DLBCL) and 21 with indolent lymphoma (IL)] due to the low number of the other subtypes. Results: PRAME expression was detected in 20 of the total 62 cases (32.3%). Nine of 33 cases with DLBCL, 7 of 21 cases with IL, 4 of 6 cases with T-NHL and both of the 2 cases of mantle cell lymphoma (MCL). Clinical variables including gender, stage, age, extranodal involvement and response to chemotherapy were not different in PRAME (+) and PRAME (-) cases. However PRAME (+) cases had longer PFS and OS than the PRAME (-) cases, however, no significant difference was found between groups in total. Furthermore, lymphoma subtype data indicated that while PRAME positivity was significantly associated with longer OS in cases with IL (p=0.049) but not in DLBCL cases (p=0.881). Multivariate Cox regression analysis showed that while response to chemotherapy was an independent risk factor, PRAME and NHL subtype were found not to be significant independent risk factors associated with the OS rate. Conclusion: PRAME expression was found in one third of the cases with NHL and there was no difference in PRAME expression in indolent lymphomas and DLBCL. Although we did not find the prognostic importance of PRAME with NHL overall, lymphoma subtype data indicated that PRAME positivity was associated with OS. This may be due to the relatively low number of the cases and also lack of comparison with RT-PCR which is the most frequently used method in detection of PRAME expression.
Authors and Affiliations
Semra Paydas, Arbil Avci Acikalin, Melek Ergin, Berna Bozkurt Duman, Gulsah Seydaoglu
Keywords
Related Articles
- EP ID EP242601
- DOI 10.9734/IBRR/2014/8832
- Views 105
- Downloads 0
Haematological Parameters of Adult and Paediatric Subjects with Sickle Cell Disease in Steady State, in Benin City, Nigeria
Background: Sickle cell disease (SCD) remains a major health burden in Sub-Saharan Africa and the management requires regular monitoring of the patients. The monitoring includes routine assessment of haematological param...
Outpatient Management of Acute Leukemia: A Systematic Review and Meta Analysis
Background/Aim: Outpatient chemotherapy administration for solid tumors is a commonly accepted practice given its advantage of easy and safe drug administration, ability to value the patient’s wish to avoid hospitalizati...
Knowledge of Rh (Rhesus) D Blood Group, Risk Factors and Burden of Rh D Alloimmunisation among Female Secondary School Students in Ikorodu, Lagos, Nigeria
Background: Rh (Rhesus) blood group antigen especially D antigen plays a pivotal role in provision of safe blood and safe pregnancy. Antigen mismatch between blood donor and recipient or pregnant woman and the foetus set...
Anti-HBc and HBV-DNA among Blood Donors in North Africa; Western Libya
Background: Post transfusion hepatitis B (PTHB) continues to be an important public health concern with regard to blood transfusion in Libya and in Africa. This concern is related to the screening test which is still use...
Blood Donors Status of HIV, HBV and HCV in Central Blood Bank in Tripoli, Libya
Background: Post transfusion infections such as hepatitis and human immunodeficiency virus infection continues to be an important public health concern with regard to blood transfusion in Libya and in Africa. This concer...